Cost-effectiveness analysis of the treatment with enalapril of chronic heart failure in Spain;Análisis coste efectividad del tratamiento con enalapril de la insuficiencia cardíaca crónica en España.

Gaceta sanitaria / S.E.S.P.A.S

Volumn 10, Issue 54, 1996, Pages 135-142

  Antonanzas Villar F ^a   Anton Botella F ^a   Echevarria Echarri L ^a  

^a UNIVERSITY OF LA RIOJA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ARTICLE; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HUMAN; SPAIN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; ENALAPRIL; HEALTH CARE COSTS; HEART FAILURE, CONGESTIVE; HUMANS; SPAIN;

EID: 16744362394     PISSN: 02139111     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-9111(96)71886-1     Document Type: Article

References (0)